Glutathione S-transferase GSTP1 genotypes are associated with response to androgen ablation therapy in advanced prostate cancer

Cancer Detection and Prevention

Volumn 26, Issue 5, 2002, Pages 376-380

  Luscombe, Christopher J ^a   French, Michael E ^a   Liu, Samson ^a   Saxby, Mark F ^a   Farrell, William E ^a   Jones, Peter W ^b   Fryer, Anthony A ^b   Strange, Richard C ^a,b  

^a UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

^b KEELE UNIVERSITY   (United Kingdom)

Author keywords

Androgen ablation therapy; GSTP1; Prostate cancer; Susceptibility

Indexed keywords

ANTIANDROGEN; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE P1; GSTP1 PROTEIN, HUMAN; ISOENZYME;

ADENOCARCINOMA; AGED; ARTICLE; CANCER STAGING; CASE CONTROL STUDY; CELL TRANSFORMATION; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; PROGNOSIS; PROSTATE TUMOR; TREATMENT OUTCOME;

ADENOCARCINOMA; AGED; ANDROGEN ANTAGONISTS; CASE-CONTROL STUDIES; CELL TRANSFORMATION, NEOPLASTIC; GENOTYPE; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSTATIC NEOPLASMS; TREATMENT OUTCOME;

EID: 0036910322     PISSN: 0361090X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-090X(02)00089-2     Document Type: Article

References (28)

1. Lichtenstein P, Holm NV, Verkasalo PK, et al. Environmental and heritable factors in the causation of cancer. New Engl J Med 2000;343:78-85.
2. Taylor JA, Hirvonen A, Watson M, et al. Association of prostate cancer with vitamin D receptor gene polymorphism. Cancer Res 1996;56:4108-10.
3. Ingles SA, Ross RK, Yu MC, et al. Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J Natl Cancer Inst 1997;89:166-70.
4. Wadelius M, Autrup J, Stubbins MJ, et al. Polymorphisms in NAT2, CYP2D6, CYP2C19 and GSTP1 and their association with prostate cancer. Pharmacogenetics 1999;9:333-40.
5. Xue W, Irvine RA, Yu MC, et al. Susceptibility to prostate cancer: Interaction between genotypes at the androgen receptor and prostate specific antigen. Cancer Res 2000;60:839-41.
6. Luscombe CJ, French ME, Liu S, et al. Prostate cancer risk: Associations with ultraviolet radiation, tyrosinase and melanocortin-1 receptor genotypes. Br J Cancer 2001;85:1504-9.
7. Matthias C, Jahnke V, Jones PW, et al. Cyclin D1, glutathione S-transferase, and cytochrome P450 genotypes and outcome in patients with upper aerodigestive tract cancers: Assessment of the importance of individual genes using multivariate analysis. Cancer Epidemiol Biomarkers Prev 1999;8:815-23.
8. Westin P, Bergh A. Apoptosis and other mechanisms in androgen ablation treatment and androgen independent progression of prostate cancer: A review. Cancer Detect Prev 1998;22:476-84.
9. Denmeade SR, Lin XS, Isaacs JT. Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer. Prostate 1996;28:251-65.
10. Tang DG, Porter AT. Target to apoptosis: A hopeful weapon for prostate cancer. Prostate 1997;32:284-93.
11. Tew KD, Ronai Z. GST function in drug and stress response. Drug Resistance Updates 1999;2:143-7.
12. Hayes JD, Strange RC. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 2000;61:154-66.
13. Harries LW, Stubbins MJ, Forman D, et al. Identification of genetic polymorphism at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 1997;18:641-4.
14. Matthias C, Bockmühl U, Jahnke V, et al. The glutathione S-transferase GSTP1 polymorphism: Effects on susceptibility to oral/pharyngeal and laryngeal carcinomas. Pharmacogenetics 1998;8:1-6.
15. Sweeney C, McClur GY, Fares MY, et al. Association between survival after treatment for breast cancer and glutathione S-transferase P1 Ile105Val polymorphism. Cancer Res 2000;60:5621-4.
16. Kote-Jarai Z, Easton D, Edwards SM, et al. Relationship between glutathione S-transferase M1, P1 and T1 polymorphisms and early onset prostate cancer. Pharmacogenetics 2001;11:325-30.
17. Shepard TF, Platz EA, Kantoff PW, et al. No association between the I105V polymorphism of the glutathione S-transferase P1 gene (GSTP1) and prostate cancer risk: A prospective study. Cancer Epidemiol Biomarkers Prev 2000;9:1267-8.
18. Adler V, Yin Z, Fuchs SY, Benezra M, et al. Regulation of JNK signalling by GSTPp. EMBO J 1999;18:1321-34.
19. Bernardini S, Bernassola F, Cortese C, et al. Modulation of GSTP1-1 activity by polymerization during apoptosis. J Cell Biochem 2000;77:645-53.
20. Esteller M, Corn PG, Urena JM, et al. Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia. Cancer Res 1998;58:4515-8.
21. Brooks JD, Weinstein M, Lin X, et al. CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev 1998;7:531-6.
22. Montironi R. Prognostic factors in prostate cancer. Pathologists glean a wealth of clinical detail from the smallest piece of tissue. Br Med J 2001;7283:378-9.
23. Shröder FH, Kranse R, Barbet N, et al. Prostate-specific antigen: A surrogate endpoint for screening new agents against prostate cancer? Prostate 2000;42:107-15.
24. Luscombe CJ, French ME, Liu S, et al. Outcome in prostate cancer: Associations with skin type and polymorphism in pigmentation-related genes. Carcinogenesis 2001;22:1343-7.
25. Young JM, Muscatello DJ, Ward JE. Are men with lower urinary tract symptoms at increased risk of prostate cancer? A systematic review and critique of the available evidence. Br J Urol Int 2000;85:1037-48.
26. Janknegt RA, Abbou CC, Bartoletti R, et al. Orchiectomy and nilutamide or placebo as treatment of metastatic prostatic cancer in a multinational double-blind randomized trial. J Urol 1993;149:77-82.
27. Cuzick J. Interaction, subgroup analysis and sample size. In: Boffetta P, Caporaso N, Cuzick J, Lang M, Vineis P, editors. Metabolic Polymorphlsms and Cancer, Lyons: IARC Scientific Publications; 1999.
28. Watson MA, Stewart RK, Smith GBJ, et al. Human glutathione S-transferase P1 polymorphisms: Relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis 1998;19:275-80.